934006-98-1

Upstream product

• 663956-74-9 1-t-butyl 2-methyl (2S,4R)-4-[2-(tetrahydro-2H-pyran-2-yloxy)-ethyl]pyrrolidine-1,2-dicarboxylate 
• 117653-37-9 methyl (2S,4R)-4-<(tert-butoxycarbonyl)methyl>pyrrolidine-2-carboxylate 
• 16217-15-5 1-benzyloxycarbonyl-4-oxo-L-proline methyl ester 
• 115545-78-3 2-methyl 1-(tert-butyl) (2S-cis)-4-(2-hydroxy-2-oxoethyl)-1,2-pyrrolidinedicarboxylate 
• 64187-48-0 methyl (2S,4R)-1-benzyloxycarbonyl-4-hydroxypyrrolidine-2-carboxylate 
• 663956-73-8 methyl (2S,4R)-1-(tert-butoxycarbonyl)-4-(2-hydroxyethyl)-1,2-pyrrolidinecarboxylate 
• 117653-38-0 C₈H₁₃NO₄ 
• 934006-94-7 methyl (2S,4R)-1-(tert-butoxycarbonyl)-4-(2-tert-butoxy-2-oxoethyl)-2-pyrrolidinecarboxylate 
• 117653-36-8 methyl (2S,4E)-1-(benzyloxycarbonyl)-4-(2-tert-butoxy-2-oxoethylidene)-2-pyrrolidinecarboxylate 

Relevant academic research and scientific papers

Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration

A series of 5β-methylprolyl-2-cyanopyrrolidine analogs were synthesized and evaluated as DPP-IV inhibitors, and the duration of their ex vivo activity was assessed. Comparison of their potency and duration of action was done among three different species.

NITROGEN-CONTAINING COMPOUNDS

A compound represented by formula (I); wherein ring A represents a nitrogen containing heterocyclic ring, ring B represents 5-membered heterocyclic ring which may have substituents, R represents a hydrogen atom or cyano and the other symbols represent as